Elevate Health vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hers beats Elevate Health overall, scoring 7.3/10 vs 7.2/10. Hers is more affordable at $199/mo vs $233/mo. Choose Elevate Health for users who want financing options and free lab work with thei. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of Elevate Health and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Elevate Health

#45 of 48

7.2/10

Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.

Visit Elevate Health

Higher Rated

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	Elevate Health	Hers
Our Score	7.2/10	7.3/10
Starting Price	$233/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want financing options and free lab work with their GLP-1 program	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#45	#35

Pros & Cons Compared

Elevate Health

Pros

+Oral semaglutide from $114/mo — one of the lowest prices for any form of semaglutide in the market
+Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
+Buy-now-pay-later financing via Affirm, Klarna, and Afterpay — removes the upfront cost barrier
+Medications sourced from FDA-registered 503B outsourcing facilities — stricter oversight than standard compounding

Cons

−Promo-dependent pricing — standard tirzepatide is $449/mo without discount, nearly double the promo price
−Select state availability only — not available nationwide
−Trustpilot rating flagged for potential review solicitation — verify independently

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

Hers edges out Elevate Health with a score of 7.3/10 vs 7.2/10. If budget is your priority, Hers starts at $199/mo compared to Elevate Health's $233/mo. Choose Elevate Health if you want: users who want financing options and free lab work with their glp-1 program. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Elevate Health nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review